WILMINGTON, DE — Incyte (Nasdaq: INCY) will release its first-quarter 2026 financial results at 7:00 a.m. ET on Tuesday, April 28, followed by a conference call at 8:00 a.m. ET.
The conference call can be accessed by dialing 877-407-3042 domestically or 201-389-0864 internationally using conference ID 13759527.
A live webcast with presentation slides will be available at https://investor.incyte.com and will remain accessible for replay for 90 days.
A replay of the conference call will be available for 30 days by dialing 877-660-6853 in the United States or 201-612-7415 internationally with the same conference ID.
Incyte develops biopharmaceutical products focused on hematology, oncology, inflammation, and autoimmune diseases.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.